We are live on ! Find out more
PGEN icon

Precigen

169 hedge funds and large institutions have $2.82B invested in Precigen in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 71 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 44

15% more capital invested

Capital invested by funds: $2.45B → $2.82B (+$369M)

8% more call options, than puts

Call options by funds: $56.1M | Put options by funds: $51.9M

0.81% more ownership

Funds ownership: 84.9%85.7% (+0.81%)

0% more funds holding

Funds holding: 169169 (0)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

Holders
169
Holders Change
Holders Change %
0%
% of All Funds
4.5%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
19
Increased
71
Reduced
44
Closed
19
Calls
$56.1M
Puts
$51.9M
Net Calls
+$4.2M
Net Calls Change
-$27.4M

PGEN Hedge Fund Activity: Q3 2016 in Review

169 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2016, worth a combined $2.82B — up 15% from $2.45B a quarter earlier.

Fund positioning in PGEN was balanced in Q3 2016: 19 funds opened new positions, 19 closed out, 71 added to existing stakes and 44 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $20.3M. The largest seller was AQR Capital Management, cutting an estimated $7.4M.

  • 169 institutional investors held Precigen (PGEN) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $2.82B of Precigen stock for Q3 2016, up 15% quarter-over-quarter.
  • 19 funds opened new Precigen positions in Q3 2016 and 19 closed out, a net change of 0 holders.
  • The largest Precigen buyer in Q3 2016 was First Trust Advisors, an estimated $20.3M added.
  • The largest Precigen seller in Q3 2016 was AQR Capital Management, an estimated $7.4M sold.

Based on aggregated 13F filings for Q3 2016.